Data mining analysis of miR-638 and key genes interaction in cisplatin resistant triple-negative breast cancer
Cisplatn is one of the chemotherapy for the treatment of triple‐negatve breast cancer (TNBC), but its effectveness is limited because of the phenomenon of chemoresistance. miR‐638 was shown to regulate chemoresistance; however, it has never been validated in the cisplatn‐resistant tumor from patents....
Main Authors: | Adam Hermawan, Herwandhani Putri |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Gadjah Mada, Yogyakarta
2019-12-01
|
Series: | Indonesian Journal of Biotechnology |
Subjects: | |
Online Access: | https://jurnal.ugm.ac.id/ijbiotech/article/view/48732 |
Similar Items
-
Turmeric Inhibits MDA-MB-231 Cancer Cell Proliferation, Altering miR-638-5p and Its Potential Targets
by: Murat Kaya, et al.
Published: (2024-04-01) -
Dysregulation of miR-638 in diabetic nephropathy and its role in inflammatory response
by: Mei Lin, et al.
Published: (2021-10-01) -
Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers
by: Young Hwa Soung, et al.
Published: (2020-08-01) -
miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
by: Liu C, et al.
Published: (2020-12-01) -
MiR-638 repressed vascular smooth muscle cell glycolysis by targeting LDHA
by: Chen Shiyuan, et al.
Published: (2019-12-01)